Trades on 1 secondary market
Altos Labs
Altos Labs is a biotechnology company pursuing cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease, injury, and the disabilities that can occur throughout life. Launched publicly in January 2022 with roughly $3 billion in initial funding from i
Altos Labs is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.